Every Form 4 that SeaStar Medical Holding Corporation Warrant (ICUCW) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ICUCW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ICUCW filings page.
SeaStar Medical Holding Corp (ICU) reported that Chief Financial Officer Michael Messinger purchased 750 shares of Common Stock on August 18, 2026 in an open market or private transaction at $3.27 per share. Following this purchase, he directly owns 2,500 shares of SeaStar Medical common stock.
Schlorff Eric reported acquisition or exercise transactions in this Form 4 filing.
SeaStar Medical Holding Corp Chief Executive Officer Eric Schlorff received an equity grant in the form of restricted stock units. The award covers 10,288 shares of common stock at a stated price of $0.00 per share, reflecting a compensation-related grant rather than an open-market purchase.
According to the filing, the restricted stock units will vest in three equal installments on July 1, 2026, November 1, 2026, and March 1, 2027. After this grant, Schlorff holds 50,140 shares of SeaStar Medical common stock directly.
Chung Kevin reported acquisition or exercise transactions in this Form 4 filing.
SeaStar Medical Holding Corp reported that Chief Medical Officer Kevin Chung received a grant of 7,202 shares of common stock in the form of restricted stock units. These RSUs were awarded at no cash cost to him as part of his compensation.
The award will vest in three equal installments on July 1, 2026, November 1, 2026, and March 1, 2027. After this grant, Chung directly holds 28,021 shares of SeaStar Medical common stock, showing his equity-based alignment with the company’s long-term performance.
Vincent Bernadette N reported acquisition or exercise transactions in this Form 4 filing.
SeaStar Medical Holding Corp director Bernadette N. Vincent reported an equity compensation grant on a Form 4. She received 4,000 shares in the form of restricted stock units that will vest in full on July 1, 2027. These units were awarded at a stated price of $0.00 per share, reflecting a compensation grant rather than a market purchase. After this award, her directly held common stock position increased to 8,200 shares, indicating a relatively small but notable addition to her ownership stake through long-term incentive compensation.
Neuman John reported acquisition or exercise transactions in this Form 4 filing.
SeaStar Medical Holding Corp director John Neuman received an equity award of 4,000 shares of common stock in the form of restricted stock units (RSUs). The award was granted at a price of $0.00 per share as compensation, not as an open-market purchase.
The RSUs will vest in full on July 1, 2027, meaning Neuman must remain eligible through that date to receive the underlying shares. Following this grant, he holds 16,200 shares of SeaStar Medical common stock in total as reported in this filing.
Van Heel Kenneth reported acquisition or exercise transactions in this Form 4 filing.
SeaStar Medical Holding Corp director Kenneth Van Heel received a grant of 4,000 restricted stock units. These RSUs vest in full on July 1, 2027, meaning he will receive the underlying shares if he remains eligible on that date. After this award, he directly holds 11,940 shares of common stock.
Baird Jennifer A reported acquisition or exercise transactions in this Form 4 filing.
SeaStar Medical Holding Corp director Jennifer A. Baird received an equity grant of 4,000 shares in the form of restricted stock units. These RSUs relate to common stock with a par value of $0.0001 per share and will vest in full on July 1, 2027.
After this award, Baird holds a total of 10,620 shares of SeaStar Medical common stock directly, reflecting her updated ownership position as reported in this Form 4 filing.
SeaStar Medical Holding Corp director Kenneth Van Heel reported receiving a grant of restricted stock units (RSUs) under the company’s equity program. On February 6, 2026, he acquired 3,000 shares of common stock at a price of $0 as an award.
According to the filing, these RSUs will vest in full on February 6, 2027, meaning the shares become fully owned on that date if vesting conditions are met. After this grant, Van Heel beneficially owns 7,940 shares of SeaStar Medical common stock directly.
SeaStar Medical Holding Corp director John Neuman reported a stock-based award. On February 6, 2026, he received 3,000 shares of common stock at a stated price of $0, reported as an acquired transaction.
After this grant, Neuman beneficially owns 12,200 shares of SeaStar Medical common stock in direct form. The filing notes that the 3,000-share award represents restricted stock units (RSUs) that will vest in full on February 6, 2027.
SeaStar Medical Holding Corp director Vincent Bernadette N reported receiving 3,000 shares of common stock on February 6, 2026 under transaction code A, indicating an acquisition. The filing notes this represents a restricted stock unit (RSU) award that will vest in full on February 6, 2027. The shares were acquired at a stated price of $0 per share, leaving the director with 4,200 shares of beneficially owned common stock held directly after the grant.
SeaStar Medical Holding Corp executive Towne Bradford K reported receiving 7,500 shares of common stock as a stock-based award. The shares, reported at a price of $0 per share, increased the executive's directly held stake to 9,050 shares.
The award is in the form of restricted stock units that vest in three equal installments on the first, second and third anniversaries of February 6, 2026. Towne Bradford K serves as the company's Principal Accounting Officer.
SeaStar Medical Holding Corp’s Chief Medical Officer Kevin Chung reported receiving 15,000 shares of common stock as a restricted stock unit (RSU) award on February 6, 2026. The RSUs vest in equal installments on the first, second, and third anniversaries of that date. After this grant, Chung beneficially owned 20,819 shares directly.
SeaStar Medical Holding Corp disclosed that its Chief Executive Officer, Eric Schlorff, received an award of 30,000 shares of common stock in the form of restricted stock units on February 6, 2026, at a grant price of $0 per share.
The RSU award vests in three equal installments on the first, second and third anniversaries of February 6, 2026. Following this grant, Schlorff beneficially owned 39,852 shares of SeaStar Medical common stock, held directly.